4//SEC Filing
Nofi Michael 4
Accession 0001705477-25-000005
CIK 0001710072other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 6:03 PM ET
Size
8.1 KB
Accession
0001705477-25-000005
Insider Transaction Report
Form 4
Nofi Michael
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2025-11-10+43,750→ 43,750 totalExercise: $0.00Exp: 2035-11-10→ Common Stock (43,750 underlying) - Award
Stock Options (Right to buy)
2025-11-10+262,500→ 262,500 totalExercise: $18.28Exp: 2035-11-10→ Common Stock (262,500 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on November 10, 2026.
- [F2]1/4th of the shares subject to the option become vested and exercisable on November 10, 2026 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001705477
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 6:03 PM ET
- Size
- 8.1 KB